Posts with tag Medicines

This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation. To view our first article and the whole series, please click here. One of the key changes to the legislation – and the focus of much debate - is a review of the rules regarding regulatory data protection. In the draft text of the new Directive, the Commission devotes an entire chapter to regulatory data and market protection. The proposed new framework is more complicated than...